Pharma Talk Radio

In September 2012, TransCelerate Biopharma launched with the aim of simplifying and accelerating the delivery of innovative medicines to patients.  What progress has really been made and what are the realistic goals for 2015? In our 2015 kick off radio show, Clinical Air Episode #13, host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer talks with Dalvir Gill, PhD, CEO of Transcelerate and Andy Lee, MD, SVP, Head of Global Clinical Trial Operations at Merck. In this frank discussion, we learn: What’s working well and changes for 2015? Is Tanscelerate performing better or differently from other collaborations? How have engagements with outside organizations advanced?  Where do gaps remain? How are new areas selected and scope defined? Thoughts on implementing new ideas New role for CROs What deliverables does Tanscelerate anticipate for 2015?  

Join host, Craig H. Lipset, Head of Clinical Innovation, R&D, Pfizer lead a discussion on what it really means to partner with patients in clinical trials. Guests include: Jeri Burtchell, Founder, Partners in Research Regina Holliday, Artist and Medical Advocate For more information on Jeri's new launch, visit: Healthivibe.com and for Regina walking gallary, google Regina Holliday, walking gallary. For more information on the topic of Patients as Partners, visit www.theconferenceforum.org. The Conference Forum presented a program in March 2014 fully dedicated to understanding the journey a patient takes in clinical trials. Also take a look at Disruptive Innovations to Advance Clinical Trials scheduled for September 11-12, 2014 in Boston. This event addresses significant innovation to help improve a patients experience in a clinical trial.  

Join host, Craig Lipset, Head of Clinical Innovation, R&D, Pfizer lead a discussion on Investing in the future of clinical research. Guests include: Todd Pietri, Co-Founder, Milestone Ventures Jeremy Sohn, Managing Director, MPM Capital  VC views on: Disruption in the clinical trial space Entrepreneurs Finding opportunities (incubators and accelerators) Good sources of deal flows Investing in technology or people? Mobile Big data Beyond the pill and more.... Craig, Todd and Jeremy will also be speaking at Mobile@Dpharm on September 10th at the Farimont Copley Plaza hotel in Boston. This event helps drug developers get their arms around the mobile/digital clinical trial landscape and figure out: How mobile is innovating clinical trials What parts of clinical trials mobile/digital technology is currently impacting How mobile technology is making clinical trials cheaper, easier and more accurate How mobile/digital is increasing the efficacy of drugs What the true value is to clinical trials Opportunities There is an opportunity to participate in creating a clinical trial app. Mobile@Dpharm will also be of interest to investors and app developers. Following this one day event is DPharm: Disruptive Innovations to Advance Clinical Trials. For more information, visit www.theconferenceforum.org or call 646 350 2580.  

In Clinical Air episode # 8, host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer hosts a show discussing investigators as partners in clinical research. Guests include: Christine Pierre, President, Society of Clinical Research Jacalyn Kent, Director, Clinical Development Information & Optimization, Eli Lilly Key topics include:  Misunderstandings around Remote Based Monitoring  Training and communication challenges for remote site managers Transcelerate update What are the real cost savings around RBM...are we just shifting costs? Real time data and how this should affect sites and payments Reducing burdens to the sites Investigator turn over rate, making sites sustainable      

In 2013 Pfizer launched the Pfizer Blue Button Project, a first-of-it’s-kind initiative enabling patients who have participated in clinical trials the opportunity to download their individual clinical data.  Using the Blue Button standard launched by the White House, patients will be empowered to use the data to improve their overall health and wellness, from sharing with healthcare providers to powering clinical risk assessments.  In this show, our host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer speaks to the leaders behind these initiatives to find out why they launched, initial learnings, and where the projects may go if successful. Also joining Craig is Thomas Krohn, Business Lead for the Lilly Clinical Open Innovation Team.  Host:   Craig Lipset, Head of Clinical Innovation, R&D, Pfizer  Guests: Adam Dole, Presidential Innovation Fellow, The White House Thomas Krohn, Business Lead for the Lilly Clinical Open Innovation Team Jennifer Wulff, Director, Clinical Innovation, Pfizer

How a patient experiences a clinical trial is changing. Access, ease, efficiencey, safety and better quality data collection are the target goals. This episode features some of the emerging technologies together with a discussion on the opportunities and challenges to include patient access, recruitment and retention. Predictions for 2014 are shared by our guests. Host: Craig H. Lipset, MBA Head of Clinical Innovation, Worldwide Research and Development, Pfizer Inc. Guests: Tomasz Sablinski, MD, PhD Founder & CEO, Transparency Life Sciences Komathi Stem Senior Director, Product Development, Innovation Lead, Genentech, A Member of the Roche Group, United States  

Join guests Kerri Weingard, ANP, COO, Verified Clinical Trials and Susan Salgado, PhD, Founder, Hospitality Quotient as they identify the barriers and limitations in engaging patients in clinical trials. What we can do about it through communication and service? Hosted by Valerie Bowling, Executive Director, the Conference Forum, this episode addresses one of the hottest topics at the Patients as Partners event scheduled for March 3-4, 2014 in Philadelphia. For more information, visit www.theconferenceforum.org About our Guests: Susan Reilly Salgado, PhD founded Hospitality Quotient with Danny Meyer in 2010.  Hospitality Quotient offers customized advice and training to inspire, build and sustain a company culture of service in organizations across industries.  In addition to her PhD, Susan holds a BS and an MBA from Lehigh University. Susan has also served as an instructor in organizational behavior and business strategy at NYU and as a guest lecturer at Lehigh. Kerri Weingard is the chief operating officer at Verified Clinical Trials (VCT), a New York-based firm specializing in ensuring the integrity of medical studies and clinical trials by creating a database of research study participants trials. Ms. Weingard, who is a nurse practitioner, holds a master’s degree in science from Stony Brook University. She has conducted over 500 clinical trials as a research coordinator and sub-investigator.     

This episode provides a recap on what's happening with mobile/sensors in clinical trials especially as they affect patients. Host: Craig Lipset, Head of Clinical Innovation, R&D, Pfizer, Inc.  Guests: Tim Davis, CEO & Co-Founder, Exco InTouch Abbe Steel, Vice President of Patient & Physician Services, UBC 

Eli Lilly and Quintiles entered into a co-investment partnership to develop a new solution using computer-assisted designs that emphasize the improvement of scientific and operational outcomes of clinical trials. The results were shared at the DPharm 2013 event and project leaders from both companies will talk to our host Craig Lipset on how this formation is doing a year later. Also joining Craig is Jeff Lee, CEO, Omniscience to discuss featured news and trends in clinical trial innovation and in particular mobile applications. Host: Craig Lipset, MBA, Head of Clinical Innovation, R&D, Pfizer, Inc. Guests: Jeffrey Kasher, PhD, VP & COO, Eli Lilly & Company Jeff Lee, CEO, Omniscience Mobile Rick Sax, MD, SVP Clinical Design & Reporting Services, Quintiles  

A panel of executives from leading pharma and the venture capital community at the DPharm Disruptive Innovations conference recently awarded the 2013 Disruptive Innovator of the Year title to Medidata Solutions and Spaulding Clinical Research. They won for their collaboration on a novel study evaluating the impact of mobile and cloud-based technology on patient engagement for improved health outcomes in the diabetes community. Host Craig Lipset, Head of Clinical Innovation, R&D at Pfizer speaks with Dr. Andrew Lee of Sanofi on key takeaways from the 2013 DPharm conference along with the CEOs of  the winning companies to learn more about their collaboration. Guests: Andrew Lee, MD, SVP, Deputy Head of Clinical Sciences & Operations, Sanofi Glen De Vries, President of Medidata Solutions Randy Spaulding, Founder and CEO of Spaulding Clinical Research    

Join us in a discussion on serving patients in clinical trials. Making clinical trials more accessible for patients Emerging technologies / iPads and informed consent Disruption Headlines in the news Host: Craig Lipset, MBA Head of Clinical Innovation, R&D, Pfizer Inc. Guests: Andreas Koester, MD, PhD VP, Clinical Trial Innovation & External Alliances,  Janssen Anthony Costello, CEO, Mytrus

The CMO of a biotech is like no other job in the world. The CMO is not only responsible for delivering on clinical trials, but also is a key player in the company's fundraising efforts.   From the Chief Medical Officer Summit, please join co-chairs Dr. Greg Fiore, CMO of the The Medicines Company and Dr. Steven Zelenkofske, CMO of Regado together with opening presenter Dr. Tyler Martin, CMO & Founder of Great Plains Biotechnology, to discuss the role of the CMO and how to best manage it.  Topics include:  What should a CMO be focused on? Functioning with restrictive capital Supporting a CEO who does not have experience in the therapeutic area you are in charge of The great balancing act

Drs. Christopher Gallen, CEO at SK BioPharmaceuticals and Mitchell Katz, Executive Director, Medical Research Operations at Purdue Pharma, in a candid conversation on navigating the complexities of Global Clinical Trials and addressing topics including: Why global trials? Why are global trials so expensive? How are companies re-thinking global trials? What's happening with global outsourcing? Thoughts on emerging markets and patient recruitment What can we do to help mitigate the risks of global trials?  

Join host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer with guests Joe Kim, Clinical Operations Director, Shire and Dr. Hugo Stevenson, physician and serial entrepreneur, as they discuss innovation transforming the clinical trial space to include:  *   Mobile technology and apps  *   Clinical trials and diversity  *   Google Glass for health  *   Investigator database sharing  *   Key motivations for innovators and moreThe opinions shared by Craig and our guests are those of the speakers and do not necessarily reflect the opinions of their employers.